The investigators created a cohort of patients with juvenile inflammatory rheumatisms with the purpose to follow them prospectively, and investigate the tolerance and efficacy of immunosuppresive and biological agents.
The JIR-cohort has to be filled by an authorized investigator during or after the consultation. Each patient much be followed at least once a year. Different data are requested in the JIR-cohort: diagnosis, treatment, adverse events and outcome.
Study Type
OBSERVATIONAL
Enrollment
15,000
Number of severe and very severe adverse event as a mesure of safety and tolerability
Time frame: 10 years
Number of treatments prescribed off label
Time frame: 10 Years
Length in months of drug survival in patient treated with at least two consecutive biological agents
Time frame: 10 Years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Hôpital Reine Fabiola
Brussels, Belgium
CHU Charleroi
Charleroi, Belgium
UZ Leuven
Leuven, Belgium
CHC Liège
Liège, Belgium
CHR Citadelle
Liège, Belgium
CHU Belfort
Belfort, France
CHRU Besançon
Besançon, France
Hôpital Pellegrin enfants
Bordeaux, France
CHRU Brest
Brest, France
Hôpital Femme Mère Enfant
Bron, France
...and 35 more locations